ストックスクリーナーアプリを入手
0.6899
2.97%
0.0199
アフターアワーズ：
.67
-0.0199
-2.88%
前日終値:
$0.67
開ける：
$0.6775
24時間の取引高:
113.52K
Relative Volume:
1.22
時価総額：
$16.28M
収益：
-
当期純損益:
$-7.33M
株価収益率:
-1.8581
EPS:
-0.3713
ネットキャッシュフロー:
$-8.02M
1週間 パフォーマンス:
-2.14%
1か月 パフォーマンス:
+2.18%
6か月 パフォーマンス:
-69.87%
1年 パフォーマンス:
-83.77%
1日の値動き範囲:
$0.6209
$0.6999
1週間の範囲:
$0.6209
$0.76
52週間の値動き範囲:
$0.59
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Compare GNTA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
0.6899 | 15.81M | 0 | -7.33M | -8.02M | -0.3713 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-06-29 | 再開されました | ROTH MKM | Buy |
| 2022-07-25 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-13 | 開始されました | Maxim Group | Buy |
Genenta Science Spa Adr (GNTA) 最新ニュース
Genenta Science to close US subsidiary and transition CFO to consulting role - Investing.com Canada
Genenta Science to close US subsidiary and transition CFO to consulting role By Investing.com - Investing.com South Africa
Genenta Science to Close U.S. Subsidiary and Shift CFO to Consulting Role - TipRanks
Genenta Science Moves Into Aerospace With Majority Investment Deal for Sòphia High Tech - The Globe and Mail
GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill
Genenta signs Definitive Agreements with Sophia High Tech - GlobeNewswire Inc.
Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - The Globe and Mail
Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India
Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com
What's going on in today's pre-market session - chartmill.com
Genenta Moves to Acquire Control of Italian Space-Defense Supplier Sòphia High Tech - TipRanks
Genenta Science Cancels Late-March Vote on Rebrand to Saentra Forge - The Globe and Mail
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business - Finviz
11 Best Italian Stocks to Buy in 2026 - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail
Genenta Science Piv A Strategic Shift from Biotech to Defense - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Aprea Therapeutics (APRE) - The Globe and Mail
Genenta Science stock soars on strategic pivot to defense sector By Investing.com - Investing.com Australia
Genenta Science stock soars on strategic pivot to defense sector - Investing.com
Genenta to Rebrand as Saentra Forge and Pivot into Italian National-Security Industrial Consolidator - TipRanks
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS) - The Globe and Mail
Genenta Science (NASDAQ:GNTA) Trading Up 0.7% – Here’s What Happened - Defense World
Operating cash flow per share of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView — Track All Markets
Return on equity % of Genenta Science SpA Sponsored ADR – LSX:A3C9EK - TradingView
Healthy Upside Potential: Genenta Science SpA ADR (GNTA) - Setenews
Genenta Science stock soars after update on glioblastoma treatment study By Investing.com - Investing.com Australia
Genenta Science stock soars after update on glioblastoma treatment study - Investing.com
Genenta Science (NASDAQ:GNTA) Shares Down 3.4% – Should You Sell? - Defense World
Candlestick signals on Genenta Science S.p.A. Depositary Receipt stock todayProduct Launch & Short-Term Trading Opportunity Alerts - newser.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Dogwood Therapeutics (DWTX) - The Globe and Mail
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting - MSN
Genenta Science Secures $15 Million in Registered Direct Offering - The Globe and Mail
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - inkl
Genenta Science Appoints New Board Member and Confirms CEO - The Globe and Mail
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com UK
These stocks are moving in today's pre-market session - ChartMill
Genenta Science Soars Following Strategic Collaboration with Anemocyte - StocksToTrade
Genenta Science Stock Skyrockets After Strategic Collaboration Announcement - StocksToTrade
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
Genenta Science Reports Reduced Losses and Strengthened Balance Sheet for H1 2025 - TipRanks
Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO - The Globe and Mail
Genenta Science Spa Adr (GNTA) 財務データ
収益
当期純利益
現金流量
EPS
1.77%
0.25%
大文字化:
|
ボリューム (24 時間):